Bailard’s Boston Scientific BSX Stock Holding History

Bailard’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.57M	Sell	173,433 -13,909	-7%	-$644K	0.15%	119
2026 Q2	$8M	Sell	187,342 -25,855	-12%	-$1.4M	0.16%	116
2026 Q1	$13.4M	Buy	213,197 +11,041	+5%	+$883K	0.31%	72
2025 Q4	$19.3M	Sell	202,156 -1,291	-0.6%	-$127K	0.43%	51
2025 Q3	$19.9M	Sell	203,447 -2,090	-1%	-$216K	0.43%	52
2025 Q2	$22.1M	Buy	205,537 +275	+0.1%	+$27.8K	0.51%	46
2025 Q1	$20.7M	Buy	205,262 +1,237	+0.6%	+$125K	0.53%	44
2024 Q4	$18.2M	Buy	204,025 +270	+0.1%	+$23.8K	0.47%	51
2024 Q3	$17.1M	Buy	203,755 +32,637	+19%	+$2.57M	0.44%	55
2024 Q2	$13.2M	Buy	171,118 +16,053	+10%	+$1.18M	0.36%	60
2024 Q1	$10.6M	Buy	155,065 +31,441	+25%	+$2.02M	0.29%	81
2023 Q4	$7.15M	Buy	+123,624	New	+$6.6M	0.21%	107

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Fisher Funds Management Auckland, New Zealand $3.44B AUM 17.27% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Bailard's BSX Position: Q3 2026 in Review

Bailard reduced its Boston Scientific (BSX) stake by 7.4% in Q3 2026, selling an estimated $644K and leaving 173,433 shares worth $7.57M. The position accounts for 0.15% of the portfolio, ranked #119.

Bailard first reported a position in BSX in Q4 2023 and has held it in 12 quarters since. The position peaked at $22.1M in Q2 2025. 215 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

Bailard held 173,433 shares of Boston Scientific worth $7.57M as of Q3 2026.
Bailard sold 13,909 Boston Scientific shares in Q3 2026, an estimated $644K.
Boston Scientific made up 0.15% of Bailard's portfolio in Q3 2026, its #119 holding.
Bailard first reported a position in Boston Scientific in Q4 2023 and has held it in 12 quarters since.
Bailard's Boston Scientific position peaked at $22.1M in Q2 2025.
215 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Bailard's 13F filing for Q3 2026, filed 13 Oct 2026.